Skip to main content
OpenTrials
Completed

NCT Number: NCT01932281

SierraSil Joint Formula 14 as an Ergogenic Aid to Performance in Athletes

The purpose of this study is to examine whether supplementation with SierraSil can improve anaerobic power and reduce muscle fatigue in a group of well-trained athletes.

A secondary purpose is to examine the effect of SierraSil on the severity of delayed onset muscle soreness.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–35 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

University of British Columbia

Vancouver, British Columbia, V6T 1Z3, Canada

About this study

This is a double blind, crossover, pilot study that will examine the effect of SierraSil supplementation on the determinants of human performance. Anaerobic capacity, muscle fatigue, the severity of delayed onset muscle soreness (DOMS) and markers of inflammation will be measured before and after 3 weeks of supplementation with SierraSil or placebo. There will be a 3 week washout period prior to the crossover to ensure SierraSil supplementation has no residual effect.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • no contraindications to strenuous exercise

Exclusion criteria

  • muscle or joint injury
  • taking any form of anti-inflammatory or pain medication
  • females due to the variability that might be introduced due to the phases of the menstrual cycle

Treatment and study plan

SierraSil

Dietary Supplement

SierraSil is a natural, mineral supplement currently used to improve joint health and function.

Placebo

Dietary Supplement

Sugar pill manufactured to mimic SierraSil 667 mg capsule

Primary outcomes

  1. change in total anaerobic capacity

    Time frame: change from baseline at 3 weeks

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Registry information

Official study title

SierraSil as an Ergogenic Aid to Performance in Athletes

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Aug 30, 2013
Registry last updated
Jul 15, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.